We are live on ! Find out more
AQA

Alpha Quant Advisors Portfolio holdings

AUM $99.8M
This Fund
S&P 500
This Quarter Est. Return
+10.82%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$99.8M
AUM Growth
+$3.41M
Cap. Flow
-$5.41M
Cap. Flow %
-5.42%
Top 10 Hldgs %
18.21%
Holding
423
New
64
Increased
61
Reduced
101
Closed
73

Top Buys

Rank Stock Value
1
CLX icon
Clorox
CLX
+$1.17M
2
NRG icon
NRG Energy
NRG
+$882K
3
LUV icon
Southwest Airlines
LUV
+$321K
4
ALXN
Alexion Pharmaceuticals
ALXN
+$268K
5
SYK icon
Stryker
SYK
+$246K

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$1.6M
2
INTU icon
Intuit
INTU
+$1.14M
3
DAL icon
Delta Air Lines
DAL
+$992K
4
BIIB icon
Biogen
BIIB
+$331K
5
IFF icon
International Flavors & Fragrances
IFF
+$285K

Sector Composition

Rank Sector Weight
1 Healthcare 20.78%
2 Technology 17.86%
3 Consumer Staples 15.81%
4 Industrials 9.66%
5 Consumer Discretionary 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
101
Regeneron Pharmaceuticals
REGN
$70.9B
$256K 0.26%
624
-136
-18% -$56K
MRK icon
102
Merck
MRK
$315B
$255K 0.26%
3,188
-1,562
-33% -$117K
EW icon
103
Edwards Lifesciences
EW
$49.4B
$254K 0.25%
3,978
-783
-16% -$44.7K
DGX icon
104
Quest Diagnostics
DGX
$23.3B
$252K 0.25%
+2,807
New +$243K
WFC icon
105
Wells Fargo
WFC
$265B
$251K 0.25%
5,200
COST icon
106
Costco
COST
$417B
$250K 0.25%
1,033
+919
+806% +$201K
AGN
107
DELISTED
Allergan plc
AGN
$248K 0.25%
1,693
-67
-4% -$9.71K
ILMN icon
108
Illumina
ILMN
$28.2B
$246K 0.25%
816
-319
-28% -$93K
T icon
109
AT&T
T
$152B
$246K 0.25%
10,387
+207
+2% +$4.76K
SJI
110
DELISTED
South Jersey Industries, Inc.
SJI
$246K 0.25%
7,600
NKTR icon
111
Nektar Therapeutics
NKTR
$2.31B
$241K 0.24%
477
-322
-40% -$191K
CMS icon
112
CMS Energy
CMS
$22.8B
$240K 0.24%
+4,307
New +$227K
UNH icon
113
UnitedHealth
UNH
$387B
$234K 0.23%
949
-180
-16% -$45.9K
HUM icon
114
Humana
HUM
$48B
$214K 0.21%
804
-376
-32% -$108K
HRL icon
115
Hormel Foods
HRL
$14B
$208K 0.21%
4,646
-3,366
-42% -$144K
CI icon
116
Cigna
CI
$74.5B
$194K 0.19%
1,207
-8,750
-88% -$1.6M
FE icon
117
FirstEnergy
FE
$28.1B
$192K 0.19%
+4,624
New +$184K
ABMD
118
DELISTED
Abiomed Inc
ABMD
$187K 0.19%
654
-75
-10% -$24.9K
LOW icon
119
Lowe's Companies
LOW
$117B
$164K 0.16%
1,500
EMB icon
120
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.6B
$163K 0.16%
1,477
IJH icon
121
iShares Core S&P Mid-Cap ETF
IJH
$122B
$158K 0.16%
4,160
HYG icon
122
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
$157K 0.16%
1,814
EFA icon
123
iShares MSCI EAFE ETF
EFA
$76.5B
$96K 0.1%
1,470
+1
+0.1% +$63
DVY icon
124
iShares Select Dividend ETF
DVY
$23.8B
$79K 0.08%
802
SDY icon
125
State Street SPDR S&P Dividend ETF
SDY
$21.8B
$74K 0.07%
740

Similar funds

Alpha Quant Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Alpha Quant Advisors held 423 positions worth $99.8M, up 3.5% from $96.4M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Alpha Quant Advisors withdrew a net $5.41M in Q1 2019, closing 73 positions and reducing 101 holdings. Its most notable exit was International Flavors & Fragrances, an estimated $285K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Alpha Quant Advisors opened a new position in Alexion Pharmaceuticals worth $291K.

  • Alpha Quant Advisors's largest Q1 2019 buy was Alexion Pharmaceuticals: 2,155 shares worth $291K.
  • Alpha Quant Advisors added most to Clorox in Q1 2019, an estimated $1.17M increase.
  • Alpha Quant Advisors's biggest Q1 2019 reduction was Cigna, cutting an estimated $1.6M.
  • Alpha Quant Advisors fully exited International Flavors & Fragrances in Q1 2019, selling an estimated $285K.
  • Alpha Quant Advisors's ten largest holdings make up 18% of its $99.8M portfolio in Q1 2019.
  • Alpha Quant Advisors opened 64 new positions and closed 73 in Q1 2019.
  • Alpha Quant Advisors's portfolio value rose 3.5% quarter-over-quarter to $99.8M.

Based on Alpha Quant Advisors's 13F filing for Q1 2019, filed 8 May 2019.